Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $6.7000 (-12.36%) ($6.6850 - $6.7000) on Mon. Aug. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.16% (three month average) | RSI | 47 | Latest Price | $6.7000(-12.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.9% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(31%) GLD(20%) VIXM(20%) BND(18%) IBB(17%) | Factors Impacting BCRX price | BCRX will decline at least -1.58% in a week (0% probabilities). XLRE(-43%) XLP(-37%) SPLV(-28%) DIA(-25%) XLI(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.58% (StdDev 3.16%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.32 | 5 Day Moving Average | $7.08(-5.37%) | 10 Day Moving Average | $7.36(-8.97%) | 20 Day Moving Average | $7.32(-8.47%) | To recent high | -24.3% | To recent low | 0% | Market Cap | $1.182b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |